Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.37910191 |
2 | response to type I interferon (GO:0034340) | 4.31736099 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.28112489 |
4 | type I interferon signaling pathway (GO:0060337) | 4.22859786 |
5 | cellular response to type I interferon (GO:0071357) | 4.22859786 |
6 | complement activation, classical pathway (GO:0006958) | 4.06125067 |
7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.96663298 |
8 | regulation of protein activation cascade (GO:2000257) | 3.83772139 |
9 | regulation of complement activation (GO:0030449) | 3.82142632 |
10 | complement activation, alternative pathway (GO:0006957) | 3.67990777 |
11 | complement activation (GO:0006956) | 3.59166204 |
12 | negative regulation of fibrinolysis (GO:0051918) | 3.54482367 |
13 | acute-phase response (GO:0006953) | 3.39049230 |
14 | protein activation cascade (GO:0072376) | 3.38289155 |
15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.37476236 |
16 | regulation of fibrinolysis (GO:0051917) | 3.27311040 |
17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.14328506 |
18 | negative regulation of cell killing (GO:0031342) | 3.14328506 |
19 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.13855950 |
20 | response to interferon-beta (GO:0035456) | 3.05410317 |
21 | myeloid dendritic cell differentiation (GO:0043011) | 3.02099130 |
22 | T-helper 1 type immune response (GO:0042088) | 2.98861243 |
23 | negative regulation of protein activation cascade (GO:2000258) | 2.93240816 |
24 | immunoglobulin mediated immune response (GO:0016064) | 2.92102793 |
25 | negative regulation of viral genome replication (GO:0045071) | 2.91103529 |
26 | regulation of humoral immune response (GO:0002920) | 2.90823692 |
27 | exogenous drug catabolic process (GO:0042738) | 2.87703282 |
28 | fibrinolysis (GO:0042730) | 2.83850735 |
29 | regulation of interferon-alpha production (GO:0032647) | 2.83354771 |
30 | regulation of apoptotic cell clearance (GO:2000425) | 2.82762862 |
31 | detection of bacterium (GO:0016045) | 2.82274086 |
32 | detection of other organism (GO:0098543) | 2.80377538 |
33 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.79398060 |
34 | negative regulation of complement activation (GO:0045916) | 2.78295755 |
35 | germinal center formation (GO:0002467) | 2.75654620 |
36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.75138359 |
37 | response to protozoan (GO:0001562) | 2.72290223 |
38 | defense response to protozoan (GO:0042832) | 2.71881834 |
39 | positive regulation of interferon-alpha production (GO:0032727) | 2.71623418 |
40 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.71431012 |
41 | drug catabolic process (GO:0042737) | 2.70362629 |
42 | protein carboxylation (GO:0018214) | 2.69350590 |
43 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.69350590 |
44 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.68997719 |
45 | L-phenylalanine catabolic process (GO:0006559) | 2.67575502 |
46 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.67575502 |
47 | response to interferon-alpha (GO:0035455) | 2.66529243 |
48 | acute inflammatory response (GO:0002526) | 2.65230377 |
49 | modulation by symbiont of host immune response (GO:0052553) | 2.64598380 |
50 | positive regulation by symbiont of host defense response (GO:0052509) | 2.64598380 |
51 | modulation by symbiont of host defense response (GO:0052031) | 2.64598380 |
52 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.64598380 |
53 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.64598380 |
54 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.64598380 |
55 | regulation of T cell tolerance induction (GO:0002664) | 2.64540338 |
56 | interferon-gamma secretion (GO:0072643) | 2.63371329 |
57 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.61358152 |
58 | low-density lipoprotein particle remodeling (GO:0034374) | 2.61268200 |
59 | macrophage activation involved in immune response (GO:0002281) | 2.60824539 |
60 | negative regulation of humoral immune response (GO:0002921) | 2.60778981 |
61 | ethanol oxidation (GO:0006069) | 2.60753261 |
62 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.60583374 |
63 | epoxygenase P450 pathway (GO:0019373) | 2.60396557 |
64 | NIK/NF-kappaB signaling (GO:0038061) | 2.59988622 |
65 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.58238789 |
66 | L-phenylalanine metabolic process (GO:0006558) | 2.58238789 |
67 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.57857994 |
68 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.55535112 |
69 | cellular glucuronidation (GO:0052695) | 2.55402982 |
70 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.54686169 |
71 | positive regulation of type 2 immune response (GO:0002830) | 2.53779243 |
72 | cholesterol efflux (GO:0033344) | 2.53569558 |
73 | negative regulation of innate immune response (GO:0045824) | 2.52781264 |
74 | detection of external biotic stimulus (GO:0098581) | 2.51880454 |
75 | response to peptidoglycan (GO:0032494) | 2.50295211 |
76 | cellular response to interferon-gamma (GO:0071346) | 2.49543826 |
77 | uronic acid metabolic process (GO:0006063) | 2.48954052 |
78 | glucuronate metabolic process (GO:0019585) | 2.48954052 |
79 | * lipoprotein metabolic process (GO:0042157) | 2.48946850 |
80 | peptide catabolic process (GO:0043171) | 2.48537724 |
81 | plasma lipoprotein particle assembly (GO:0034377) | 2.48043761 |
82 | negative regulation of blood coagulation (GO:0030195) | 2.47559693 |
83 | negative regulation of hemostasis (GO:1900047) | 2.47559693 |
84 | positive regulation of extracellular matrix organization (GO:1903055) | 2.47543663 |
85 | response to interferon-gamma (GO:0034341) | 2.47505452 |
86 | myeloid dendritic cell activation (GO:0001773) | 2.47228120 |
87 | regulation of regulatory T cell differentiation (GO:0045589) | 2.47029614 |
88 | plasma lipoprotein particle remodeling (GO:0034369) | 2.46798043 |
89 | protein-lipid complex remodeling (GO:0034368) | 2.46798043 |
90 | macromolecular complex remodeling (GO:0034367) | 2.46798043 |
91 | cellular response to exogenous dsRNA (GO:0071360) | 2.45412158 |
92 | phospholipid efflux (GO:0033700) | 2.45172193 |
93 | positive regulation of antigen processing and presentation (GO:0002579) | 2.44051107 |
94 | regulation of antigen processing and presentation (GO:0002577) | 2.42697861 |
95 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.42375879 |
96 | regulation of tolerance induction (GO:0002643) | 2.41239300 |
97 | regulation of hypersensitivity (GO:0002883) | 2.41109006 |
98 | negative regulation of viral entry into host cell (GO:0046597) | 2.40885407 |
99 | positive regulation of tolerance induction (GO:0002645) | 2.40397996 |
100 | negative regulation of cholesterol transport (GO:0032375) | 2.40217816 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.71152283 |
2 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.47750014 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.75203440 |
4 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.40141335 |
5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.39725165 |
6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.78277893 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.72756898 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.63120467 |
9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.59968384 |
10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.35031058 |
11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.16057248 |
12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.14026676 |
13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.13722590 |
14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.09734072 |
15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.07965486 |
16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.03382897 |
17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.99128566 |
18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.96342734 |
19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.95233603 |
20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.93871495 |
21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92007459 |
22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.90446885 |
23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.89396346 |
24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.86822518 |
25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.84931718 |
26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.75371119 |
27 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.73233075 |
28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.71480294 |
29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70981126 |
30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64691631 |
31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.62293690 |
32 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58147574 |
33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.57624428 |
34 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.57487749 |
35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53001345 |
36 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.52160198 |
37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.50492034 |
38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48974614 |
39 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.47090011 |
40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45991017 |
41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42222367 |
42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39400609 |
43 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.34415218 |
44 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29343552 |
45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27951889 |
46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.27558244 |
47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.25470067 |
48 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23775744 |
49 | MAF_26560356_Chip-Seq_TH1_Human | 1.22058944 |
50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21815508 |
51 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21528527 |
52 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.21170744 |
53 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20849315 |
54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18371266 |
55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17173090 |
56 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16600234 |
57 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.15433670 |
58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15148642 |
59 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13883163 |
60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13820679 |
61 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12444239 |
62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10851348 |
63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10445082 |
64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10224617 |
65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.10085600 |
66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08155337 |
67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07400513 |
68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06958640 |
69 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.06895903 |
70 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.06201233 |
71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04530273 |
72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04472024 |
73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04244698 |
74 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03406473 |
75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03200730 |
76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02981540 |
77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02934201 |
78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02728460 |
79 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.02050899 |
80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02049557 |
81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01831278 |
82 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01245056 |
83 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.98591516 |
84 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97568344 |
85 | MYB_26560356_Chip-Seq_TH2_Human | 0.97022029 |
86 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.94562762 |
87 | MYB_26560356_Chip-Seq_TH1_Human | 0.94370142 |
88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.92932119 |
89 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92181631 |
90 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91722754 |
91 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.91137968 |
92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90436892 |
93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89813077 |
94 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89813077 |
95 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89190709 |
96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87664981 |
97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87418396 |
98 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87319876 |
99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85124722 |
100 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84862975 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.50436155 |
2 | MP0003724_increased_susceptibility_to | 3.39506978 |
3 | MP0003436_decreased_susceptibility_to | 3.02517254 |
4 | MP0003303_peritoneal_inflammation | 2.97377676 |
5 | MP0009785_altered_susceptibility_to | 2.95494839 |
6 | MP0005360_urolithiasis | 2.85235475 |
7 | MP0000685_abnormal_immune_system | 2.74326238 |
8 | MP0006082_CNS_inflammation | 2.65170437 |
9 | MP0001835_abnormal_antigen_presentation | 2.62569544 |
10 | MP0005365_abnormal_bile_salt | 2.52268364 |
11 | MP0005387_immune_system_phenotype | 2.49026261 |
12 | MP0001790_abnormal_immune_system | 2.49026261 |
13 | MP0002138_abnormal_hepatobiliary_system | 2.44439632 |
14 | MP0005025_abnormal_response_to | 2.36178818 |
15 | MP0003195_calcinosis | 2.26124223 |
16 | MP0005085_abnormal_gallbladder_physiolo | 2.21556169 |
17 | MP0002148_abnormal_hypersensitivity_rea | 2.20981661 |
18 | MP0003806_abnormal_nucleotide_metabolis | 2.18264573 |
19 | MP0009840_abnormal_foam_cell | 2.16643580 |
20 | MP0008875_abnormal_xenobiotic_pharmacok | 2.13129402 |
21 | MP0002419_abnormal_innate_immunity | 1.98116128 |
22 | MP0001800_abnormal_humoral_immune | 1.96137265 |
23 | MP0005671_abnormal_response_to | 1.92531269 |
24 | MP0005000_abnormal_immune_tolerance | 1.90699401 |
25 | MP0001533_abnormal_skeleton_physiology | 1.87258851 |
26 | MP0010155_abnormal_intestine_physiology | 1.82508326 |
27 | MP0003191_abnormal_cellular_cholesterol | 1.82078879 |
28 | MP0003300_gastrointestinal_ulcer | 1.82054527 |
29 | MP0005058_abnormal_lysosome_morphology | 1.79101914 |
30 | MP0005451_abnormal_body_composition | 1.78388498 |
31 | MP0004947_skin_inflammation | 1.78123531 |
32 | MP0002723_abnormal_immune_serum | 1.76041523 |
33 | MP0002452_abnormal_antigen_presenting | 1.70381516 |
34 | MP0003183_abnormal_peptide_metabolism | 1.69322235 |
35 | MP0003252_abnormal_bile_duct | 1.67727802 |
36 | MP0008469_abnormal_protein_level | 1.61646733 |
37 | MP0001845_abnormal_inflammatory_respons | 1.60104267 |
38 | MP0009333_abnormal_splenocyte_physiolog | 1.57699743 |
39 | MP0001666_abnormal_nutrient_absorption | 1.55248159 |
40 | MP0009764_decreased_sensitivity_to | 1.51306868 |
41 | MP0005164_abnormal_response_to | 1.43338063 |
42 | MP0001819_abnormal_immune_cell | 1.41391218 |
43 | MP0010329_abnormal_lipoprotein_level | 1.40204604 |
44 | MP0002420_abnormal_adaptive_immunity | 1.39510301 |
45 | MP0005464_abnormal_platelet_physiology | 1.37841944 |
46 | MP0003075_altered_response_to | 1.37458885 |
47 | MP0005023_abnormal_wound_healing | 1.35872125 |
48 | MP0000858_altered_metastatic_potential | 1.32515201 |
49 | MP0002933_joint_inflammation | 1.30859113 |
50 | MP0003453_abnormal_keratinocyte_physiol | 1.28821618 |
51 | MP0005166_decreased_susceptibility_to | 1.28336619 |
52 | MP0003172_abnormal_lysosome_physiology | 1.27552903 |
53 | MP0002405_respiratory_system_inflammati | 1.26954235 |
54 | MP0004019_abnormal_vitamin_homeostasis | 1.25768589 |
55 | MP0001873_stomach_inflammation | 1.20701477 |
56 | MP0004510_myositis | 1.20420529 |
57 | MP0003866_abnormal_defecation | 1.15069915 |
58 | MP0004883_abnormal_blood_vessel | 1.13434030 |
59 | MP0000609_abnormal_liver_physiology | 1.11200740 |
60 | MP0009643_abnormal_urine_homeostasis | 1.11178444 |
61 | MP0000604_amyloidosis | 1.10643303 |
62 | MP0002132_abnormal_respiratory_system | 1.10180859 |
63 | MP0003868_abnormal_feces_composition | 1.09302118 |
64 | MP0009763_increased_sensitivity_to | 1.09049757 |
65 | MP0005083_abnormal_biliary_tract | 1.04917198 |
66 | MP0002998_abnormal_bone_remodeling | 1.03919363 |
67 | MP0005332_abnormal_amino_acid | 1.03183952 |
68 | MP0000716_abnormal_immune_system | 1.01760155 |
69 | MP0002876_abnormal_thyroid_physiology | 1.00023498 |
70 | MP0002166_altered_tumor_susceptibility | 0.96239240 |
71 | MP0003045_fibrosis | 0.95058992 |
72 | MP0000249_abnormal_blood_vessel | 0.94347061 |
73 | MP0002118_abnormal_lipid_homeostasis | 0.93984786 |
74 | MP0005319_abnormal_enzyme/_coenzyme | 0.92819897 |
75 | MP0003656_abnormal_erythrocyte_physiolo | 0.92320526 |
76 | MP0002136_abnormal_kidney_physiology | 0.91640054 |
77 | MP0000343_altered_response_to | 0.91215278 |
78 | MP0001663_abnormal_digestive_system | 0.90179471 |
79 | MP0003448_altered_tumor_morphology | 0.89879972 |
80 | MP0005310_abnormal_salivary_gland | 0.89125502 |
81 | MP0006054_spinal_hemorrhage | 0.88644884 |
82 | MP0004264_abnormal_extraembryonic_tissu | 0.86146219 |
83 | MP0005167_abnormal_blood-brain_barrier | 0.85901725 |
84 | MP0002254_reproductive_system_inflammat | 0.84876174 |
85 | MP0008004_abnormal_stomach_pH | 0.84821028 |
86 | MP0004043_abnormal_pH_regulation | 0.84501865 |
87 | MP0001851_eye_inflammation | 0.84379173 |
88 | MP0010234_abnormal_vibrissa_follicle | 0.83576545 |
89 | MP0008260_abnormal_autophagy | 0.81479111 |
90 | MP0005390_skeleton_phenotype | 0.80560687 |
91 | MP0002398_abnormal_bone_marrow | 0.78895498 |
92 | MP0002429_abnormal_blood_cell | 0.78338460 |
93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77880637 |
94 | MP0003950_abnormal_plasma_membrane | 0.77612818 |
95 | MP0003763_abnormal_thymus_physiology | 0.77314885 |
96 | MP0000465_gastrointestinal_hemorrhage | 0.77281209 |
97 | MP0003879_abnormal_hair_cell | 0.74234545 |
98 | MP0001853_heart_inflammation | 0.73112552 |
99 | MP0004858_abnormal_nervous_system | 0.69194277 |
100 | MP0003091_abnormal_cell_migration | 0.69120267 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus (HP:0002725) | 5.68236445 |
2 | Complement deficiency (HP:0004431) | 5.38863723 |
3 | Deep venous thrombosis (HP:0002625) | 5.10217526 |
4 | Abnormality of complement system (HP:0005339) | 4.68242592 |
5 | Glomerulonephritis (HP:0000099) | 4.67196187 |
6 | Eczematoid dermatitis (HP:0000976) | 4.09895348 |
7 | Orchitis (HP:0100796) | 4.04076708 |
8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.03167399 |
9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.99657882 |
10 | Retrobulbar optic neuritis (HP:0100654) | 3.83299993 |
11 | Optic neuritis (HP:0100653) | 3.83299993 |
12 | Myositis (HP:0100614) | 3.82610715 |
13 | Nephritis (HP:0000123) | 3.54447363 |
14 | Abnormality of macrophages (HP:0004311) | 3.50848292 |
15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.41177630 |
16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.41177630 |
17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.41177630 |
18 | Prolonged partial thromboplastin time (HP:0003645) | 3.40161798 |
19 | Joint hemorrhage (HP:0005261) | 3.18500033 |
20 | Purpura (HP:0000979) | 3.15661944 |
21 | Malnutrition (HP:0004395) | 3.07883322 |
22 | Recurrent bacterial skin infections (HP:0005406) | 3.05654964 |
23 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.04500482 |
24 | Gastrointestinal infarctions (HP:0005244) | 2.90287810 |
25 | Hemorrhage of the eye (HP:0011885) | 2.87453168 |
26 | Recurrent abscess formation (HP:0002722) | 2.85755913 |
27 | Hypobetalipoproteinemia (HP:0003563) | 2.84414066 |
28 | Vasculitis (HP:0002633) | 2.75972825 |
29 | Xanthomatosis (HP:0000991) | 2.71797061 |
30 | Keratoconjunctivitis sicca (HP:0001097) | 2.70994964 |
31 | Pulmonary infiltrates (HP:0002113) | 2.69875121 |
32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.69299731 |
33 | Gingival bleeding (HP:0000225) | 2.66585676 |
34 | Mediastinal lymphadenopathy (HP:0100721) | 2.62338763 |
35 | Interstitial pulmonary disease (HP:0006530) | 2.60980616 |
36 | Joint swelling (HP:0001386) | 2.59923282 |
37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.57510456 |
38 | Abnormality of the common coagulation pathway (HP:0010990) | 2.52654415 |
39 | Dysostosis multiplex (HP:0000943) | 2.51666409 |
40 | Gangrene (HP:0100758) | 2.49983421 |
41 | Keratoconjunctivitis (HP:0001096) | 2.47481654 |
42 | Vascular calcification (HP:0004934) | 2.43696150 |
43 | Increased serum ferritin (HP:0003281) | 2.42599369 |
44 | Mucopolysacchariduria (HP:0008155) | 2.42353020 |
45 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.42353020 |
46 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40437578 |
47 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40437578 |
48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40437578 |
49 | Meningitis (HP:0001287) | 2.34148755 |
50 | Vacuolated lymphocytes (HP:0001922) | 2.33334169 |
51 | Hemoptysis (HP:0002105) | 2.32611777 |
52 | Gingivitis (HP:0000230) | 2.30059842 |
53 | Pulmonary embolism (HP:0002204) | 2.28773787 |
54 | Conjugated hyperbilirubinemia (HP:0002908) | 2.24423095 |
55 | Amyloidosis (HP:0011034) | 2.23240830 |
56 | Recurrent skin infections (HP:0001581) | 2.19999410 |
57 | Abnormality of iron homeostasis (HP:0011031) | 2.19356116 |
58 | Abnormality of the nasal mucosa (HP:0000433) | 2.19286268 |
59 | Increased IgM level (HP:0003496) | 2.18088167 |
60 | Recurrent bronchitis (HP:0002837) | 2.13717224 |
61 | Fat malabsorption (HP:0002630) | 2.13519344 |
62 | Intrahepatic cholestasis (HP:0001406) | 2.13285624 |
63 | Increased IgE level (HP:0003212) | 2.12755296 |
64 | Myocardial infarction (HP:0001658) | 2.12103758 |
65 | Nasal polyposis (HP:0100582) | 2.11561312 |
66 | Recurrent fungal infections (HP:0002841) | 2.11246478 |
67 | Abnormality of proline metabolism (HP:0010907) | 2.10723467 |
68 | Hydroxyprolinuria (HP:0003080) | 2.10723467 |
69 | Cardiovascular calcification (HP:0011915) | 2.08438658 |
70 | Stomatitis (HP:0010280) | 2.07397740 |
71 | Abnormality of the pleura (HP:0002103) | 2.03765507 |
72 | Arterial thrombosis (HP:0004420) | 2.01759819 |
73 | Pustule (HP:0200039) | 2.00031936 |
74 | Hypergammaglobulinemia (HP:0010702) | 1.98588774 |
75 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98389953 |
76 | Obstructive lung disease (HP:0006536) | 1.98389953 |
77 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.97942158 |
78 | Thrombophlebitis (HP:0004418) | 1.97078609 |
79 | Autoimmune thrombocytopenia (HP:0001973) | 1.95912816 |
80 | Urticaria (HP:0001025) | 1.95503528 |
81 | Menorrhagia (HP:0000132) | 1.95358639 |
82 | Emphysema (HP:0002097) | 1.95191801 |
83 | Chronic otitis media (HP:0000389) | 1.94538583 |
84 | Epistaxis (HP:0000421) | 1.94435490 |
85 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.92768695 |
86 | Autoimmune hemolytic anemia (HP:0001890) | 1.91734214 |
87 | Cheilitis (HP:0100825) | 1.89570033 |
88 | Anorexia (HP:0002039) | 1.87110568 |
89 | Hyperlipoproteinemia (HP:0010980) | 1.86965366 |
90 | Loss of speech (HP:0002371) | 1.84201097 |
91 | Acne (HP:0001061) | 1.83838013 |
92 | Peritonitis (HP:0002586) | 1.82473638 |
93 | Alopecia of scalp (HP:0002293) | 1.81665293 |
94 | Encephalitis (HP:0002383) | 1.80936660 |
95 | Mitral stenosis (HP:0001718) | 1.80489037 |
96 | Conical tooth (HP:0000698) | 1.79922720 |
97 | Chronic diarrhea (HP:0002028) | 1.79734719 |
98 | Increased cerebral lipofuscin (HP:0011813) | 1.79714228 |
99 | Hypolipoproteinemia (HP:0010981) | 1.79474062 |
100 | Skin rash (HP:0000988) | 1.78086939 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.17742387 |
2 | FGFR4 | 3.34581276 |
3 | MST1R | 3.18982844 |
4 | TYK2 | 3.14033418 |
5 | EPHA2 | 3.03200970 |
6 | RIPK1 | 2.72442035 |
7 | MAP3K14 | 2.64059879 |
8 | TBK1 | 2.53240722 |
9 | IRAK3 | 2.44736594 |
10 | MAP4K1 | 2.43286311 |
11 | IKBKE | 2.28990443 |
12 | FGFR3 | 2.27444625 |
13 | MAP3K3 | 2.01049965 |
14 | IRAK4 | 1.97017172 |
15 | JAK3 | 1.93984363 |
16 | JAK1 | 1.90621318 |
17 | MAPKAPK3 | 1.79320075 |
18 | RIPK4 | 1.77843084 |
19 | BLK | 1.73813386 |
20 | EPHB1 | 1.73469185 |
21 | TRIB3 | 1.71472173 |
22 | EPHA3 | 1.63527311 |
23 | IKBKB | 1.60131864 |
24 | ZAP70 | 1.59996574 |
25 | MATK | 1.52700416 |
26 | CDC42BPA | 1.52472633 |
27 | KIT | 1.49173640 |
28 | CSK | 1.39003621 |
29 | TGFBR2 | 1.28873586 |
30 | DDR2 | 1.22259430 |
31 | SIK1 | 1.20801860 |
32 | MAP3K13 | 1.13981000 |
33 | TXK | 1.12605775 |
34 | CSF1R | 1.08747977 |
35 | IRAK1 | 1.06362358 |
36 | PRPF4B | 1.06141068 |
37 | MAP3K1 | 1.00766163 |
38 | PTK6 | 1.00316111 |
39 | MAP3K11 | 0.97744724 |
40 | GRK6 | 0.97004971 |
41 | MAP3K2 | 0.95969272 |
42 | MAP2K6 | 0.94087393 |
43 | SYK | 0.92988988 |
44 | JAK2 | 0.92797297 |
45 | TAOK3 | 0.92777375 |
46 | MET | 0.91740715 |
47 | GRK7 | 0.91440099 |
48 | MAP2K3 | 0.90456115 |
49 | FGR | 0.88051281 |
50 | PDPK1 | 0.86663067 |
51 | TAOK1 | 0.84387643 |
52 | PIK3CA | 0.84277074 |
53 | NME2 | 0.83685112 |
54 | STK24 | 0.83100827 |
55 | HIPK2 | 0.82752884 |
56 | LYN | 0.81332957 |
57 | CHUK | 0.79341230 |
58 | TAOK2 | 0.78540024 |
59 | LCK | 0.74356745 |
60 | BTK | 0.72766276 |
61 | MAPK11 | 0.71584528 |
62 | PDK1 | 0.70912152 |
63 | SIK2 | 0.67532675 |
64 | ADRBK2 | 0.67036830 |
65 | TLK1 | 0.65314975 |
66 | HCK | 0.64650206 |
67 | MAP3K6 | 0.59657461 |
68 | WNK4 | 0.57956244 |
69 | PDGFRA | 0.56807941 |
70 | BMPR2 | 0.56237722 |
71 | PRKG2 | 0.56214029 |
72 | MAPKAPK2 | 0.55973146 |
73 | PRKAA2 | 0.54603188 |
74 | MAP3K7 | 0.54105911 |
75 | SIK3 | 0.52368684 |
76 | PIM2 | 0.51008501 |
77 | FER | 0.47722894 |
78 | BMX | 0.47539208 |
79 | ITK | 0.47038400 |
80 | SMG1 | 0.46003764 |
81 | PRKCQ | 0.45930707 |
82 | IGF1R | 0.45327035 |
83 | TNK2 | 0.44313762 |
84 | PDGFRB | 0.44185880 |
85 | MELK | 0.43714554 |
86 | PRKD2 | 0.43530015 |
87 | MAPK15 | 0.42604197 |
88 | MAPK7 | 0.40890717 |
89 | TRPM7 | 0.38330169 |
90 | PRKCD | 0.38007369 |
91 | NLK | 0.37369859 |
92 | ERBB2 | 0.36843892 |
93 | RPS6KA6 | 0.34504200 |
94 | RPS6KL1 | 0.34255155 |
95 | RPS6KC1 | 0.34255155 |
96 | FES | 0.34096590 |
97 | PTK2 | 0.31859946 |
98 | EPHB2 | 0.30252108 |
99 | LMTK2 | 0.30090556 |
100 | MAP2K2 | 0.29983459 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.22250963 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.18476974 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 2.30399003 |
4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.12248897 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.10860869 |
6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.09626234 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.04661458 |
8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.99520453 |
9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.99472839 |
10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.89394753 |
11 | Asthma_Homo sapiens_hsa05310 | 1.88280512 |
12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87522412 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.80235146 |
14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79397515 |
15 | Pertussis_Homo sapiens_hsa05133 | 1.69368941 |
16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67291980 |
17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.66239721 |
18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.65985865 |
19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.58819639 |
20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.57778809 |
21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.57255670 |
22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57021826 |
23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.56829656 |
24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.52747053 |
25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.50743204 |
26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.50422148 |
27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.50090416 |
28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45078177 |
29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.42923759 |
30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.41811817 |
31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.38340010 |
32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.34605878 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32643127 |
34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28318826 |
35 | Influenza A_Homo sapiens_hsa05164 | 1.27947218 |
36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23800981 |
37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20894691 |
38 | Hepatitis C_Homo sapiens_hsa05160 | 1.20289524 |
39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17194220 |
40 | Malaria_Homo sapiens_hsa05144 | 1.16314876 |
41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.16210126 |
42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12937720 |
43 | * African trypanosomiasis_Homo sapiens_hsa05143 | 1.09573238 |
44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.08512487 |
45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.07834280 |
46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06864503 |
47 | Tuberculosis_Homo sapiens_hsa05152 | 1.05941505 |
48 | Measles_Homo sapiens_hsa05162 | 1.04310637 |
49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02734897 |
50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.98976223 |
51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97679853 |
52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96830093 |
53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96136062 |
54 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.95571029 |
55 | Lysosome_Homo sapiens_hsa04142 | 0.94607408 |
56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.93913849 |
57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93792811 |
58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.91796212 |
59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.91066471 |
60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.89739694 |
61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89322353 |
62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88420652 |
63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87322106 |
64 | Prion diseases_Homo sapiens_hsa05020 | 0.83350487 |
65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82149974 |
66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78136670 |
67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.77997583 |
68 | Legionellosis_Homo sapiens_hsa05134 | 0.76052635 |
69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72738484 |
70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71393059 |
71 | Bile secretion_Homo sapiens_hsa04976 | 0.70994895 |
72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70920357 |
73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68590994 |
74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65866507 |
75 | ABC transporters_Homo sapiens_hsa02010 | 0.65459861 |
76 | Phagosome_Homo sapiens_hsa04145 | 0.60355637 |
77 | Amoebiasis_Homo sapiens_hsa05146 | 0.59735136 |
78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59432582 |
79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59158146 |
80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58235512 |
81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57511290 |
82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55793584 |
83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54185072 |
84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53108143 |
85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53073242 |
86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49082560 |
87 | Apoptosis_Homo sapiens_hsa04210 | 0.47811697 |
88 | Salmonella infection_Homo sapiens_hsa05132 | 0.45890163 |
89 | Peroxisome_Homo sapiens_hsa04146 | 0.45083807 |
90 | Insulin resistance_Homo sapiens_hsa04931 | 0.45066191 |
91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44948143 |
92 | Mineral absorption_Homo sapiens_hsa04978 | 0.44626085 |
93 | Hepatitis B_Homo sapiens_hsa05161 | 0.44350541 |
94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39925683 |
95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38206431 |
96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37567761 |
97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.36719965 |
98 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.35115039 |
99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34013017 |
100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.33409081 |